Teva Pharmaceuticals USA, Inc Recalls
10 recalls on record in the United States
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal in
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
View recall details →
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal in
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
View recall details →
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal in
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
View recall details →
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.2 mg/day, supplied in c
CGMP Deviations: use of an unapproved raw material
View recall details →
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.1 mg/day, supplied in c
CGMP Deviations: use of an unapproved raw material
View recall details →
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.3 mg/day, supplied in c
CGMP Deviations: use of an unapproved raw material
View recall details →
Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pac
Superpotent and Subpotent
View recall details →
Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescri
Superpotent and Subpotent
View recall details →
Teva Pharmaceuticals USA, Inc recalls Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a)
Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
View recall details →
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal in
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
View recall details →